favicon

EMULATE

emulatebio.com•Boston•United States•Biotechnology

About Emulate

Description

Emulate specializes in next-generation Organ-on-a-Chip technology, enabling researchers to closely mimic biological systems and accurately forecast human responses. This innovative approach fosters breakthroughs in biotechnology and life sciences, enhancing medical devices, data analytics, and overall understanding in the fields of health and medicine.

Specialties

Organ-on-a-Chip Technology
ADME and Toxicology Applications
Microfluidic Device Design
Human Response Prediction
Biotechnology Research Solutions

Products & Services

Organ-Chips
Chip-R1™ Rigid Chip
Drug Dosing Solutions
Toxicology Applications
Data Analytics Tools

Contact Information

No contact information available

Competitors & Similar Companies(10)

Agena Bioscience logo

Agena Bioscience

Organovo logo

Organovo

California, • United States

Mimetas logo

Mimetas

Zuid-Holland, • Netherlands • Healthcare Technology

High-throughput organ-on-a-chip, Human tissue disease models, Innovative drug discovery solutions, Scalable research platforms, Safety assessments for therapeutics

TissUse logo

TissUse

Berlin, • Germany • Biotechnology

Synlogic logo

Synlogic

Massachusetts, • United States

Reprocell logo

Reprocell

Kanagawa, • Japan • Biotechnology

InSphero logo

InSphero

Zurich, • Switzerland • Biotechnology

3D In Vitro Models, Non-animal Drug Testing, Cell-Based Assays, Transformative Drug Discovery, Ethical Biotechnology Solutions

Ncardia logo

Ncardia

Hainaut Province, • Belgium • Biotechnology

Induced pluripotent stem cells (iPSC), Innovative screening assays, Efficient differentiation processes, Cellular product development, Advanced therapeutic candidate support

Cellink logo

Cellink

Hesperos logo

Hesperos

News & Media

Search Terms:
emulate
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation

Featured News

favicon

IPO Update: EMulate Therapeutics Finalizes IPO Plans (Pending:EMTX) | Seeking Alpha

Jan 5, 2023
Public Offering (IPO)
Explore more business signals about Emulate

Frequently Asked Questions about Emulate

Where is Emulate located?
The headquarter of Emulate is located in Boston, Massachusetts, United States
What is the official website of Emulate?
The official website of Emulate is https://www.emulatebio.com
What industry does Emulate belong to?
Emulate belongs to the Biotechnology, Medical Devices and Equipment, Data Analytics and Business Intelligence, Biotechnology and Life Sciences industry.
What are the specialties of Emulate?
Emulate specializes in Organ-on-a-Chip Technology, ADME and Toxicology Applications, Microfluidic Device Design, Human Response Prediction, Biotechnology Research Solutions.
What products and services is Emulate likely to offer?
Emulate offers Organ-Chips, Chip-R1™ Rigid Chip, Drug Dosing Solutions, Toxicology Applications, Data Analytics Tools.
Who are the competitors of Emulate?
Competitors of Emulate are Agena Bioscience, Organovo, Mimetas, TissUse, Synlogic, Reprocell, InSphero, Ncardia, Cellink, Hesperos.
What does Emulate do?
Emulate specializes in next-generation Organ-on-a-Chip technology, enabling researchers to closely mimic biological systems and accurately forecast human responses. This innovative approach fosters breakthroughs in biotechnology and life sciences, enhancing medical devices, data analytics, and overall understanding in the fields of health and medicine.
What are the social media links of Emulate?
Social media links of Emulate areTwitterLinkedInInstagram

Quick Links

OverviewCompetitorsNews & MediaFAQs

Edit Request

Report an ErrorEdit ProfileSubmit New Profile